View : 116 Download: 0

Conditioned medium from human palatine tonsil mesenchymal stem cells attenuates acute graft-vs.-host disease in mice

Title
Conditioned medium from human palatine tonsil mesenchymal stem cells attenuates acute graft-vs.-host disease in mice
Authors
Cho K.-A.Kim Y.-H.Park M.Kim H.J.I.Woo S.-Y.Park J.-W.Ryu K.-H.
Ewha Authors
유경하박주원
SCOPUS Author ID
유경하scopus; 박주원scopus
Issue Date
2019
Journal Title
Molecular Medicine Reports
ISSN
1791-2997JCR Link
Citation
Molecular Medicine Reports vol. 19, no. 1, pp. 609 - 616
Keywords
Allogeneic hematopoietic stem cell transplantationGraft-vs.-host diseaseImmune cell migrationPalatine tonsil mesenchymal stem cellTSG-6
Publisher
Spandidos Publications
Indexed
SCIE; SCOPUS WOS scopus
Document Type
Article
Abstract
Graft-vs.-host disease (GVHD) is a severe and potentially life-threatening complication of hematopoietic stem cell transplantation. Approximately 50% of patients exhibiting GVHD will not benefit from conventional steroid treatment. Although several second-line treatments are available for these patients, their prognoses remain poor due to the increased risk of infection, immunosuppression-mediated toxicity and incomplete GVHD remission, which occurs in the majority of cases. Mesenchymal stem cells (MSCs), a multipotent cell population, possess broad immunosuppressive activity and are a reportedly effective treatment of GVHD. However, the therapeutic effects of conditioned medium from MSCs on GVHD have not been demonstrated. In the present study, the efficacy of conditioned medium from human palatine tonsil-derived MSCs (T-MSC-CM) was validated against GVHD in mice. The suppressive function of T-MSC-CM on immune cell chemotaxis was confirmed in vitro. A systemic infusion of T-MSC-CM in mice with GVHD resulted in prolonged survival, rapid recovery from weight loss and reduced pathological damage in numerous GVHD-targeted organs. Furthermore, lymphocyte gene expression was significantly downregulated in GVHD mice administered T-MSC-CM. These results indicate that T-MSC-CM is a promising cellular agent to prevent or treat transplantation-associated complications such as GVHD. © Spandidos Publications. All rights reserved.
DOI
10.3892/mmr.2018.9659
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE